Golden
MPM Capital

MPM Capital

U.S-based venture capital firm funding companies in U.S., Europe, and India.

MPM Capital is a venture capital firm founded in 1996. The firm was founded by Luke Evnin and Ansbert Gadicke. It is primarily based in Cambridge, Massachusetts although it also has offices in Brisbane, California and Kansas City, Kansas. As of March 2019, the firm is managing 33 active companies in its portfolio and has sold off its ownership in 199 companies. Its most recent investment was in Harpoon Therapeutics on November 2018, a company developing clinical-stage immunotherapy .

Funding

MPM Capital specializes in funding life sciences and healthcare companies. It provides financing at various stages of development, from seed to buyout. The firm invests on companies worldwide, but it prioritizes funding companies that are based in the United States, Europe, and India. Since its establishment, the firm has managed to amass a total fund of $2.9 billion across ten funding series. Its most recent funding round was held in February 2019 which collected $400 million.

Timeline

Associated investment funds

Funded Companies

35 Results
Company
Company
Description
Description
Website
Website
Industry
Industry
Location
Location
Funding rounds
Funding rounds
TriNetX is a Cambridge, Massachusetts-based company.
-
Allozyne is a company developing technologies in protein-based therapeutics founded by William Andrew Goddard III.
A biopharmaceutical company developing therapeutics for the treatment of cancer, infectious diseases and autoimmune disorders
A biopharmaceutical company focused on the discovery and development of epigenetic medicines to treat cancer and other disease
A pharmaceutical company focused developing products for pain management and women’s healthcare
A biopharmaceutical company developing therapeutics for the treatment of central nervous system illnesses
A biotechnology company that develops therapeutic antibodies for treating infectious diseases and inflammation
A pharmaceutical company that develops therapies targeting solid and hematological cancer tumors
A company developing treatments for Alzheimer’s disease and other neurological diseases
A life science devices company focused on the discovery and development of protein biomarkers as diagnostic tests
A biopharmaceutical company developing small molecule drugs for asthma, chronic allergy and inflammatory conditions
A biopharmaceutical company developing therapeutics for the treatment of type 1 and type 2 diabetes
-

People

Name
Role
LinkedIn

Ansbert Gadicke

Co-Founder/Managing Director



Lauren Cauley

Chief Financial Officer



Luke Evnin

Co-Founder/Managing Director



Sarah Reed

Chief Operating Officer



Todd Foley

Managing Director



Further reading

Title
Author
Link
Type
Date









Documentaries, videos and podcasts

Title
Date
Link





Companies

Company
CEO
Location
Products/Services

Chiasma







DigiTix Partners







Entrada







Naked Biome







Rhythm







Syndax







References